PATENT CLAIM ANALYSIS

Application Number: 15969109
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "252130"]

Abstract:
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for increased solubility are disclosed. Combination therapy with antibodies and PK/PD data are also disclosed.

Claim (Index 58):
The method of  claim 55 , wherein the solubilizing agent is a polysorbate.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 93.0
- Lexical Diversity: 1.51515
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13999670', '15355910', '15016599', '13724396', '15705639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7456295297403914
- 35 USC 102 Novelty (BERT): 0.5266088839964009
- Combined Prediction Score: 0.7237274651659924
- Mean Citation Score: 254.32372400000003
- Max Citation Score: 322.6672700000001
- Similarity Product: 208.89191268225915

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test